Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population-Reference-Cited by-同舟云学术

Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population

Published:2017-04 Issue:4 Volume:76 Page:632-638
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Asgari Maryam M.,Ray G. Thomas,Geier Jamie L.,Quesenberry Charles P.

Publisher

Elsevier BV

Subject

Dermatology

Reference26 articles.

1. Psoriasis prevalence among adults in the United States;Rachakonda;J Am Acad Dermatology,2014

2. National Psoriasis Foundation. About psoriasis. Available from: URL: http://www.psoriasis.org/about-psoriasis/treatments/severity. Accessed March 15, 2015.

3. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study;Dubreuil;Rheumatology,2014

4. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review;Horreau;J Eur Acad Dermatol Venereol,2013

5. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients;Kothary;J Am Acad Dermatol,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics for Psoriasis;Dermatologic Clinics;2024-07

2. Maligne Transformation einer Porokeratosis Mibelli bei einem Patienten mit Psoriasis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-04

3. Malignant transformation of porokeratosis of Mibelli in a psoriatic patient;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-02-19

4. Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of the literature;Leukemia & Lymphoma;2023-07-26

5. Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials;Dermatology and Therapy;2023-06-23